Information for Authors

Download a PDF version of the Canadian Journal of Hospital Pharmacy’s (CJHP) Author Guidelines (Version française.)

Please note:
 Each author, including co-authors, must submit an International Committee of Medical Journal Editors (ICMJE) Uniform Disclosure Form for Potential Conflicts of Interest with their manuscript submission. This form is available here.

Ready to submit your manuscript? Read our submission preparation checklist first, and then login to our manuscript submission system.

Author Resources

Research Tools for Authors, Editors, and Reviewers (PDF)

Guidelines for Stability Studies:

  1. "Policy for Publication of Chemical Stability Study Manuscripts" Can J Hosp Pharm. 1990;43(1):3.
  2. "Avoiding Common Flaws in Stability and Compatibility Studies of Injectable Drugs" Am J Hosp Pharm. 1983;40:1159-60.
  3. "Stability studies: Five years later" Am J Hosp Pharm. 1988;45:1569-72.
  4. “Guidelines for submitting adverse event reports for publication” Pharmacoepidemiology and Drug Safety. 2007;16:581-87.

Delayed Open Access

While CJHP’s Editorial, Point Counterpoint, and Commentary from the Presidential Team are immediately accessible upon publication, all other articles are embargoed for the duration of 6 months. A pay-per-view system has been introduced for embargoed articles.

Authors who wish to have their articles immediately open access can do so by paying a $100 fee to forgo the embargo period. Simply complete the CJHP Authorship Fee Form.